Are you or a colleague interested in getting more involved with the Midwest Chapter in a leadership capacity?
Please consider nominating yourself or someone you know for a leadership role in SCCM-MWC by completing a very brief survey.
https://t.co/rFfcR3cQA1
We performed our 1st SBRT for refractory VT yesterday for a 71 y/o male with a history of ICM, ICD who had failed 2 ablations, surgery, and AAD therapy. We spent over 1 year planning and coordinating the details. I am grateful to all who helped make this possible.@MidAmericaHeart
Presented at CCR Down Under 2025:
In a randomized trial involving critically ill patients undergoing intubation in EDs or ICUs, the use of ketamine for the induction of anesthesia did not lead to significantly lower in-hospital mortality than etomidate. Full trial results: https://t.co/ovSy71Gi1j
@CritCareReviews
Honoring the Life and Legacy of Dr. Robert H. Bartlett - Grand Rounds today at the Department of Cardiac Surgery of @umichmedicine, with James Mault, Jennifer C. Romano, Kristopher Barrett Deatrick, Alvaro Rojas-Peña and James R. Maul celebrating their and our mentor.
I am pleased to serve as guest editor alongside @md_monaco@JDAndriaUrsoleo for a special themed issue on cardiogenic shock and cardiac arrest in @FrontMedicine - please consider submitting your papers to us!
https://t.co/JoQH0w7ZUE
Up next for #TeachingTuesday we have Dr. Paganoni (@rafael_paganoni), PGY2 resident at Saint Luke's Hospital of Kansas City. He will weigh in on the debate of heparin versus bivalirudin in ECSL patients!
It is with a heavy heart that we announce the passing of Robert Bartlett, M.D. Best known as the 'Father of ECMO,' Bartlett's contributions to science and research have saved numerous lives and changed how we view medicine today. Read his obituary here. https://t.co/wgELXe3sMY
◾️In Memoriam of Robert H. Bartlett, MD 1939-2025
Without Dr. Bartlett, there is no ECMO: he saved more than 100,000 patients through his life’s work. He changed the world.
He will forever be the Father of ECMO.
Vale, Dr B
🔗 https://t.co/RyDvDyXIsw
🎥 https://t.co/Vd4zvjI319
Wieruszewski et al. 'Dosing Reliability of Direct Thrombin Inhibitors in Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis' https://t.co/b4c6MISicK @pwierusz#SystematicReview#ECMO
#JournalWatch Only 23.8% of Critical Care PGY2s report having a formal rotation caring for the critically ill obstetric patient, and those who did felt significantly more comfortable caring for that patient population (p < 0.001) #critPRN
published today @RENIN#angiotensin2
Angiotensin II can be used to decrease the doses of non-angiotensin II vasopressors, and renin concentration could potentially help with prognostication of patients with distributive shock.
https://t.co/vU8CjBECvK
The Cardiovascular Structural Intervention Fellowship through @UMKCMedSchool and @MidAmericaheart accepts one candidate per academic year. Fellows benefit from getting hands-on training from renowned specialists.
Learn more and request an application now: https://t.co/ZhEIgzthee
Mark your calendar to join the Research Certificate presentation tonight from 5-6:30 PM. You don't want to miss Andrew Smith discussing research methodology! 🤔
Join us for another PGY2 CE Spotlight! This week's CE Spotlight is brought to us by Bayan Alghafli, @AboveandBayan mentored by @ChipHayesPharmD
Bayan's CE covers some important concepts in Cardio-Oncology.
Thank you for an excellent overview!
#CardioED
🔬 Dr. James Tisdale in @PurduePHPR has identified a risk factor for a specific type of drug-induced irregular heart rhythm. Read the full story to learn how this discovery could lead to improved patient care: https://t.co/4wJxk6KUiU